These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3319524)

  • 21. How is firing activity of substantia nigra cells regulated? Relevance of pattern-code in the basal ganglia.
    Rodríguez M; Pereda E; González J; Abdala P; Obeso JA
    Synapse; 2003 Sep; 49(4):216-25. PubMed ID: 12827640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the basal ganglia in the initiation of saccadic eye movements.
    Wurtz RH; Hikosaka O
    Prog Brain Res; 1986; 64():175-90. PubMed ID: 3523602
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anatomical connections of the basal ganglia].
    Fujiyama F
    Brain Nerve; 2009 Apr; 61(4):341-9. PubMed ID: 19378803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiological organization of the basal ganglia.
    Purpura DP
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():91-114. PubMed ID: 1005909
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of GABA in the basal ganglia and limbic system for behaviour.
    Scheel-Krüger J; Magelund G; Olianas M
    Adv Biochem Psychopharmacol; 1981; 29():23-36. PubMed ID: 7020365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons.
    Glowinski J; Michelot R; Chéramy A
    Adv Biochem Psychopharmacol; 1980; 22():51-62. PubMed ID: 6156583
    [No Abstract]   [Full Text] [Related]  

  • 28. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation.
    Fitsanakis VA; Au C; Erikson KM; Aschner M
    Neurochem Int; 2006; 48(6-7):426-33. PubMed ID: 16513220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?
    Lehmann J; Langer SZ
    Neuroscience; 1983 Dec; 10(4):1105-20. PubMed ID: 6320043
    [No Abstract]   [Full Text] [Related]  

  • 31. Roles of dopamine and its receptors in generation of choreic movements.
    Kanazawa I; Murata M; Kimura M
    Adv Neurol; 1993; 60():107-12. PubMed ID: 8093572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinergic and dopaminergic modulation of potassium conductances in neostriatal neurons.
    Kitai ST; Surmeier DJ
    Adv Neurol; 1993; 60():40-52. PubMed ID: 8380527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal links in the CNS: focus on dopaminergic and serotonergic regulation of striatal cholinergic neurons.
    Garattini S; Consolo S; Ladinski H
    Pol J Pharmacol Pharm; 1980; 32(2):155-64. PubMed ID: 7454621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single unit responses of substantia nigra and globus pallidus neurons to GABA agonist and antagonist drugs.
    Waszczak BL; Bergstrom DA; Walters JR
    Adv Biochem Psychopharmacol; 1981; 30():79-94. PubMed ID: 7331938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A possible mechanism of dopamine-induced synergistic disinhibition of thalamic cells via "direct" and "indirect" pathways in basal ganglia].
    Sil'kis IG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2001; 51(3):294-303. PubMed ID: 11550635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudate nucleus deprived of dopaminergic synaptic activity.
    Feltz P
    Appl Neurophysiol; 1979; 42(1-2):47-50. PubMed ID: 222207
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurons from substantia nigra increase the efficacy and potency of second messenger arising from striatal astroglia dopamine receptor.
    Hansson E; Rönnbäck L
    Glia; 1988; 1(6):393-7. PubMed ID: 2906631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pars reticulata of the substantia nigra: a window to basal ganglia output.
    Deniau JM; Mailly P; Maurice N; Charpier S
    Prog Brain Res; 2007; 160():151-72. PubMed ID: 17499113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite functions of histamine H1 and H2 receptors and H3 receptor in substantia nigra pars reticulata.
    Zhou FW; Xu JJ; Zhao Y; LeDoux MS; Zhou FM
    J Neurophysiol; 2006 Sep; 96(3):1581-91. PubMed ID: 16738217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.